Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

被引：123

作者：

Ashrafizadeh, Milad ^{[1
,2
]}

Mirzaei, Sepideh ^{[3
]}

Gholami, Mohammad Hossein ^{[4
]}

Hashemi, Farid ^{[5
]}

Zabolian, Amirhossein ^{[6
]}

Raei, Mehdi ^{[7
]}

Hushmandi, Kiavash ^{[8
]}

Zarrabi, Ali ^{[2
]}

Voelcker, Nicolas H. ^{[9
,10
,11
]}

Aref, Amir Reza ^{[12
,13
]}

Hamblin, Michael R. ^{[14
,15
]}

Varma, Rajender S. ^{[16
]}

Samarghandian, Saeed ^{[17
]}

Arostegi, I. J. ^{[18
]}

Alzola, M. ^{[18
]}

Kumar, Alan Prem ^{[19
,20
,21
]}

Thakur, Vijay Kumar ^{[22
,23
]}

Nabavi, Noushin ^{[24
,25
]}

Makvandi, Pooyan ^{[26
]}

Tay, Franklin R. ^{[27
]}

Orive, Gorka ^{[18
,28
,29
,30
,31
]}

机构：

[1] Sabanci Univ, Fac Engn & Nat Sci, Univ Caddesi 27, TR-34956 Istanbul, Turkey

[2] Sabanci Univ, Nanotechnol Res & Applicat Ctr SUNUM, TR-34956 Istanbul, Turkey

[3] Islamic Azad Univ, Fac Sci, Dept Biol, Sci & Res Branch, Tehran, Iran

[4] Islamic Azad Univ, Fac Vet Med, Kazerun Branch, Kazerun, Iran

[5] Univ Tehran, Fac Vet Med, Dept Comparat Biosci, Tehran, Iran

[6] Islamic Azad Univ, Tehran Med Sci, Young Researchers & Elite Club, Tehran, Iran

[7] Baqiyatallah Univ Med Sci, Hlth Res Ctr, Life Style Inst, Tehran, Iran

[8] Univ Tehran, Fac Vet Med, Dept Food Hyg & Qual Control, Div Epidemiol, Tehran, Iran

[9] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

[10] CSIRO, Clayton, Vic 3168, Australia

[11] Victorian Node Australian Natl Fabricat Facil, Melbourne Ctr Nanofabricat, 151 Wellington Rd, Clayton, Vic 3168, Australia

[12] Harvard Med Sch, Belfer Ctr Appl Canc Sci, Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Xsphera Biosci Inc, Dept Translat Sci, Boston, MA USA

[14] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa

[15] Iran Univ Med Sci, Radiobiol Res Ctr, Tehran, Iran

[16] Palacky Univ, Reg Ctr Adv Technol & Mat, Slechtitel 27, Olomouc 78371, Czech Republic

[17] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran

[18] Univ Basque Country, Sch Pharm, UPV EHU, NanoBioCel Res Grp, Vitoria, Spain

[19] Natl Univ Singapore, NUS Ctr Canc Res N2CR, Yong Loo Lin Sch Med, Singapore 117600, Singapore

[20] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Singapore 117599, Singapore

[21] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117599, Singapore

[22] Scotlands Rural Coll SRUC, Biorefining & Adv Mat Res Ctr, Kings Bldg, Edinburgh EH9 3JG, Midlothian, Scotland

[23] Shiv Nadar Univ, Sch Engn, Dept Mech Engn, Greater Noida 201314, Uttar Pradesh, India

[24] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H3Z6, Canada

[25] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H3Z6, Canada

[26] Ist Italiano Tecnol, Ctr Mat Interfaces, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy

[27] Augusta Univ, Grad Sch, Augusta, GA 30912 USA

[28] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain

[29] Univ Basque Country, Univ Inst Regenerat Med & Oral Implantol UIRMI, Fdn Eduardo Anitua, Vitoria, Spain

[30] Bioaraba, NanoBioCel Res Grp, Vitoria, Spain

[31] Singapore Eye Res Inst, 20 Coll Rd,Discovery Tower, Singapore, Singapore

来源：

CARBOHYDRATE POLYMERS | 2021年 / 272卷

基金：

新加坡国家研究基金会;

关键词：

CD44; Doxorubicin; Drug resistance; Endocytosis; Hyaluronic acid; Nanodelivery system; Theranostic; MESOPOROUS SILICA NANOPARTICLES; TARGETED DRUG-DELIVERY; FUNCTIONALIZED GRAPHENE OXIDE; HUMAN GASTRIC-CANCER; LONG NONCODING RNAS; IN-VITRO EVALUATION; LUNG-CANCER; CONTROLLED-RELEASE; CHITOSAN NANOPARTICLES; HYBRID NANOPARTICLES;

D O I：

10.1016/j.carbpol.2021.118491

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

An important motivation for the use of nanomaterials and nanoarchitectures in cancer therapy emanates from the widespread emergence of drug resistance. Although doxorubicin (DOX) induces cell cycle arrest and DNA damage by suppressing topoisomerase activity, resistance to DOX has severely restricted its anti-cancer potential. Hyaluronic acid (HA) has been extensively utilized for synthesizing nanoparticles as it interacts with CD44 expressed on the surface of cancer cells. Cancer cells can take up HA-modified nanoparticles through receptor mediated endocytosis. Various types of nanostructures such as carbon nanomaterials, lipid nanoparticles and polymeric nanocarriers have been modified with HA to enhance the delivery of DOX to cancer cells. Hyaluronic acid-based advanced materials provide a platform for the co-delivery of genes and drugs along with DOX to enhance the efficacy of anti-cancer therapy and overcome chemoresistance. In the present review, the potential methods and application of HA-modified nanostructures for DOX delivery in anti-cancer therapy are discussed.

引用

页数：21

共 50 条

[1] Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
Ashrafizadeh, Milad
Saebfar, Hamidreza
Gholami, Mohammad Hossein
Hushmandi, Kiavash
Zabolian, Amirhossein
Bikarannejad, Pooria
Hashemi, Mehrdad
Daneshi, Salman
Mirzaei, Sepideh
Sharifi, Esmaeel
Kumar, Alan Prem
Khan, Haroon
Hossein, Hamid Heydari Sheikh
Vosough, Massoud
Rabiee, Navid
Thakur, Vijay Kumar
Makvandi, Pooyan
Mishra, Yogendra Kumar
Tay, Franklin R.
Wang, Yuzhuo
Zarrabi, Ali
Orive, Gorka
Mostafavi, Ebrahim
EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (04) : 355 - 382
[2] Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation
Hashemi, Mehrdad
Ghadyani, Fatemeh
Hasani, Sahar
Olyaee, Yeganeh
Raei, Behnaz
Khodadadi, Marzieh
Ziyarani, Maryam Fallah
Basti, Fatemeh A.
Tavakolpournegari, Alireza
Matinahmadi, Arash
Salimimoghadam, Shokooh
Aref, Amir Reza
Taheriazam, Afshin
Entezari, Maliheh
Ertas, Yavuz Nuri
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 80
[3] A novel multi stimuli-responsive PEGylated hybrid gold/nanogels for co-delivery of doxorubicin and 6-mercaptopurine
Ghorbani, Marjan
Hamishehkar, Hamed
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2018, 92 : 599 - 611
[4] Stimuli-Responsive Nanocarrier for Co-delivery of MiR-31 and Doxorubicin To Suppress High MtEF4 Cancer
Wang, Fang
Zhang, Lingyun
Bai, Xiufeng
Cao, Xintao
Jiao, Xiangyu
Huang, Yan
Li, Yansheng
Qin, Yan
Wen, Yongqiang
ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (26) : 22767 - 22775
[5] Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms
Sun, Yuzhe
Davis, Edward
NANOMATERIALS, 2021, 11 (03) : 1 - 103
[6] Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance
Qiu, Lipeng
Xu, Jiamin
Ahmed, Kamel S. S.
Zhu, Mengqin
Zhang, Yan
Long, Miaomiao
Chen, Weijun
Fang, Wenjie
Zhang, Huijie
Chen, Jinghua
ACTA BIOMATERIALIA, 2022, 140 : 686 - 699
[7] Recent advances on chitosan/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: A comprehensive review
Alsaikhan, Fahad
Farhood, Bagher
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 280
[8] Stimuli-responsive pesticide carriers based on porous nanomaterials: A review
Zhou, Jie
Liu, Guangyang
Guo, Zhaojiang
Wang, Miao
Qi, Chenyu
Chen, Ge
Huang, Xiaodong
Yan, Shuo
Xu, Donghui
CHEMICAL ENGINEERING JOURNAL, 2023, 455
[9] Preparation and anti-tumor application of hyaluronic acid-based material for disulfide and copper ions co-delivery
Pang Long
Zhong Wei
Wang QiuBo
Feng HaoHui
Dong HaoNan
Wang Song
Cong HaiLin
Shen YouQing
Yu Bing
SCIENCE CHINA-TECHNOLOGICAL SCIENCES, 2021, 64 (09) : 2023 - 2032
[10] Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy
Liu, Qian
Li, Jia
Pu, Gaobin
Zhang, Fang
Liu, Hongyan
Zhang, Yongqing
DRUG DELIVERY, 2016, 23 (04) : 1364 - 1368

← 1 2 3 4 5 →